Octaphlorethol A isolated from Ishige foliacea inhibits α-MSH-stimulated induced melanogenesis via ERK pathway in B16F10 melanoma cells

Food Chem Toxicol. 2013 Sep:59:521-6. doi: 10.1016/j.fct.2013.06.031. Epub 2013 Jun 28.

Abstract

In this study, the potent skin-whitening effects of Octaphlorethol A (OPA) isolated from Ishige foliacea was investigated through inhibitory effect of melanin synthesis and tyrosinase activity in alpha-melanocyte stimulating hormone (α-MSH) induced B16F10 melanoma cells. OPA markedly inhibited melanin synthesis and tyrosinase activity in a concentration-dependent manner. We also found that OPA decreased microphthalmia-associated transcription factor (MITF), tyrosinase, tyrosinase-related protein-1 and -2 (TRP-1 and TRP-2) protein expressions. Moreover, OPA reduces p38 MAPK protein levels and activates extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinases (JNKs) protein expressions in B16F10 cells. A specific ERK inhibitor PD98059 significantly blocks OPA-inhibited melanin synthesis and tyrosinase activity, whereas a p38MAP and JNK inhibitor had no effect. These findings provide evidence demonstrating that the anti-melanogenic effect of OPA is mediated through the activation of ERK signal pathway in B16F10 cells. These results indicate that OPA has the potential to be used as a melanogenesis inhibitor in the food and cosmetics industry.

Keywords: Anti-melanogenesis; B16F10 melanoma cells; ERK; MITF; Octaphlorethol A (OPA).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Down-Regulation / drug effects*
  • Drug Discovery
  • Intramolecular Oxidoreductases / antagonists & inhibitors
  • Intramolecular Oxidoreductases / metabolism
  • MAP Kinase Signaling System / drug effects
  • Melanins / antagonists & inhibitors
  • Melanins / biosynthesis*
  • Melanocytes / drug effects*
  • Melanocytes / enzymology
  • Melanocytes / metabolism
  • Membrane Glycoproteins / antagonists & inhibitors
  • Membrane Glycoproteins / metabolism
  • Mice
  • Microphthalmia-Associated Transcription Factor / antagonists & inhibitors
  • Microphthalmia-Associated Transcription Factor / metabolism
  • Monophenol Monooxygenase / antagonists & inhibitors
  • Monophenol Monooxygenase / metabolism
  • Neoplasm Proteins / antagonists & inhibitors
  • Neoplasm Proteins / biosynthesis
  • Neoplasm Proteins / metabolism
  • Oxidoreductases / antagonists & inhibitors
  • Oxidoreductases / metabolism
  • Phaeophyceae / chemistry
  • Phenols / adverse effects
  • Phenols / antagonists & inhibitors
  • Phenols / isolation & purification
  • Phenols / pharmacology*
  • Pigmentation / drug effects*
  • Protein Kinase Inhibitors / pharmacology
  • Skin Lightening Preparations / adverse effects
  • Skin Lightening Preparations / chemistry
  • Skin Lightening Preparations / isolation & purification
  • Skin Lightening Preparations / pharmacology*
  • alpha-MSH / antagonists & inhibitors*
  • alpha-MSH / metabolism

Substances

  • Melanins
  • Membrane Glycoproteins
  • Microphthalmia-Associated Transcription Factor
  • Mitf protein, mouse
  • Neoplasm Proteins
  • Phenols
  • Protein Kinase Inhibitors
  • Skin Lightening Preparations
  • octaphlorethol A
  • alpha-MSH
  • Oxidoreductases
  • Tyrp1 protein, mouse
  • Monophenol Monooxygenase
  • Intramolecular Oxidoreductases
  • dopachrome isomerase